Transcend Capital Advisors, LLC Eli Lilly & CO Transaction History

Transcend Capital Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 16,538 shares of LLY stock, worth $13 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

16,538

Previous 16,931 2.32%

Holding current value

$13 Million

Previous $15.3 Million 4.42%

% of portfolio

1.01%

Previous 1.14%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $303,451 - $377,287	-393 Reduced 2.32%	16,538 $14.7 Million
Q2 2024 Jul 02, 2024	BUY	$724.87 - $909.04 $1.1 Million - $1.38 Million	1,518 Added 9.85%	16,931 $15.3 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $374,270 - $500,720	632 Added 4.28%	15,413 $12 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $176,463 - $208,027	336 Added 2.33%	14,781 $8.62 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $330,372 - $455,467	-760 Reduced 5.0%	14,445 $7.76 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $120,654 - $161,329	344 Added 2.31%	15,205 $7.13 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $264,656 - $310,826	852 Added 6.08%	14,861 $5.1 Million
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $176,209 - $205,319	548 Added 4.07%	14,009 $0
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $24,607 - $28,043	-83 Reduced 0.61%	13,461 $4.35 Million
Q2 2022 Jul 12, 2022	SELL	$278.73 - $327.27 $14,215 - $16,690	-51 Reduced 0.38%	13,544 $4.39 Million
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $14,550 - $18,082	-62 Reduced 0.45%	13,595 $3.89 Million
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $71,502 - $88,734	318 Added 2.38%	13,657 $3.77 Million
Q3 2021 Nov 04, 2021	BUY	$221.6 - $272.71 $256,169 - $315,252	1,156 Added 9.49%	13,339 $3.31 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $937,415 - $1.21 Million	5,192 Added 74.27%	12,183 $2.8 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $39,436 - $51,052	-240 Reduced 3.32%	6,991 $1.3 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $943,356 - $1.25 Million	7,231 New	7,231 $1.22 Million

Others Institutions Holding LLY

# of Institutions

4,033

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Eli Lilly & CO Transaction History